Royal Bank of Canada’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-362
Closed -$2K 7249
2024
Q1
$2K Buy
362
+317
+704% +$1.75K ﹤0.01% 6282
2023
Q4
$0 Buy
45
+14
+45% ﹤0.01% 7125
2023
Q3
$0 Sell
31
-4
-11% ﹤0.01% 7172
2023
Q2
$1K Sell
35
-68
-66% -$1.94K ﹤0.01% 6686
2023
Q1
$3K Sell
103
-127
-55% -$3.7K ﹤0.01% 6336
2022
Q4
$8K Buy
230
+161
+233% +$5.6K ﹤0.01% 6155
2022
Q3
$16K Buy
69
+32
+86% +$7.42K ﹤0.01% 5750
2022
Q2
$7K Sell
37
-54
-59% -$10.2K ﹤0.01% 6077
2022
Q1
$22K Sell
91
-145
-61% -$35.1K ﹤0.01% 6075
2021
Q4
$37K Buy
236
+80
+51% +$12.5K ﹤0.01% 6012
2021
Q3
$31K Buy
156
+58
+59% +$11.5K ﹤0.01% 5930
2021
Q2
$25K Sell
98
-11
-10% -$2.81K ﹤0.01% 5954
2021
Q1
$29K Buy
109
+15
+16% +$3.99K ﹤0.01% 5717
2020
Q4
$34K Buy
94
+69
+276% +$25K ﹤0.01% 5277
2020
Q3
$6K Hold
25
﹤0.01% 5609
2020
Q2
$7K Buy
25
+3
+14% +$840 ﹤0.01% 5487
2020
Q1
$5K Sell
22
-62
-74% -$14.1K ﹤0.01% 5557
2019
Q4
$37K Buy
+84
New +$37K ﹤0.01% 4998
2019
Q3
Sell
-11
Closed -$4K 6243
2019
Q2
$4K Buy
+11
New +$4K ﹤0.01% 5482
2018
Q4
Sell
-1
Closed 6212
2018
Q3
$0 Buy
+1
New ﹤0.01% 6315
2018
Q2
Hold
0
6126
2017
Q2
Sell
-5
Closed -$2K 5995
2017
Q1
$2K Sell
5
-6
-55% -$2.4K ﹤0.01% 5758
2016
Q4
$4K Buy
+11
New +$4K ﹤0.01% 5602
2015
Q2
Sell
-11
Closed -$91K 6168
2015
Q1
$91K Buy
+11
New +$91K ﹤0.01% 4218
2014
Q4
Hold
0
5668
2014
Q3
Hold
0
-$2K 5541
2014
Q2
Hold
0
5226